Skip to main content
SpringerLink
Log in

Perianal Bowen's disease

A clinicopathologic study of 47 patients

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: Perianal Bowen's disease is an uncommon squamous-cell carcinoma in situ usually treated by surgical excision. There are controversies concerning surgical margin extent, because the disease is likely to recur in nonexcised skin areas of the anal and perianal skin. The aims of this study were 1) to determine the recurrence rate after different surgical treatments and 2) to determine if molecular markers might have a prognostic role in perianal Bowen's disease. METHOD: Retrospective chart review from 1972 to 1993 of 47 patients with perianal Bowen's disease was undertaken. Follow-up was obtained by office visits and/or phone questionnaire. Immunohistochemical analysis for p53 protein and Ki-67 nuclear antigen was conducted on fixed tissue specimens. RESULTS: Twenty-six patients were treated by wide local excision with microscopic clearance of resection margins, 15 by local excision with only macroscopic clearance of resection margins, 5 by CO 2 laser vaporization, and 1 by abdominoperineal resection because of fecal incontinence. Median follow-up for the entire population was 104 (range, 16–273) months. The incidence of local recurrence was 23.1 percent (6/26) after wide local excision, 53.3 percent (8/15) after local excision, and 80 percent (4/5) after CO 2 -laser vaporization. Recurrence rate estimated by Kaplan-Meier analysis is statistically different ( P =0.002) between radically treated patients (wide local excision/abdominoperineal resection;n =27) and patients undergoing conservative treatment (local excision/laser vaporization;n =20). Among patients with recurrence, the median time until recurrence was 38.5 (range, 3–89) months and 41.5 (range, 4–111) months after conservative and radical treatment, respectively. Nine of 20 (45 percent) patients in the conservative group and none of the 27 patients in the radical group had multiple episodes of recurrence ( P <0.001). In addition, 3 of 20 and 0 of 27 patients in the respective groups developed an invasive cancer ( P =0.034). Positive staining for p53 protein was observed in 12 (33.3 percent) of the 36 tissue specimens available for immunohistochemical analysis. Recurrence occurred in 9 of 24 (37.5 percent) patients negative for p53 and in 6 of 12 (50 percent) patients with positive p53 expression ( P =not significant). Ki-67 antigen-graded expression from 1+ to 4+ did not reveal any correlation with incidence of recurrence. Recurrence rate did not differ by p53 and Ki-67 results, either in the overall group of 36 patients or stratified by surgical treatment groups. CONCLUSION: Wide local excision for perianal Bowen's disease leads to a significantly lower recurrence rate than local excision or laser therapy. Follow-up longer than five years is recommended because of the risk of late recurrence. p53 protein and Ki-67 antigen immunohistologic expression may not have a prognostic role in perianal Bowen's disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rickert RR, Brodkin RH, Hutter RV. Bowen's disease. CA J Clin 1977;27:160–6.

    Google Scholar 

  2. Sober AJ, Burstein JM. Precursors to skin cancer [review]. Cancer 1995;75:645–50.

    PubMed  Google Scholar 

  3. Schwartz RA, Stoll HL Jr. Epithelial precancerous lesions. New York: McGraw-Hill, 1993:804–21.

    Google Scholar 

  4. Pedersen KT, Ravnborg L, Reymann F. Morbus Bowen. Acta Derm Venereol (Stockh) 1988;68:236–9.

    Google Scholar 

  5. Beck DE, Fazio VW, Jagelman DG, Lavery IC. Perianal Bowen's disease. Dis Colon Rectum 1988;31:419–22.

    PubMed  Google Scholar 

  6. Callen JP. Bowen's disease and internal malignant disease. Arch Dermatol 1988;124:675–6.

    PubMed  Google Scholar 

  7. Holt PJ. Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery. Br J Dermatol 1988;119:231–40.

    PubMed  Google Scholar 

  8. Haberman HF, Goodall J, Llewellyn M. Extramammary Paget's disease. Can Med Assoc J 1978;118:161–2.

    PubMed  Google Scholar 

  9. Boynton KK, Bjorkman DJ. Argon laser therapy for perianal Bowen's disease: a case report. Lasers Surg Med 1991;11:385–7.

    PubMed  Google Scholar 

  10. Jones CM, Mang T, Cooper M, Wilson BD, Stoll HL. Photodynamic therapy in the treatment of Bowen's disease. J Am Acad Dermatol 1992;27:979–82.

    PubMed  Google Scholar 

  11. Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994;69:605–8.

    PubMed  Google Scholar 

  12. Fijan S, Honigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol 1995;133:282–8.

    PubMed  Google Scholar 

  13. Marfing TE, Abel ME, Gallagher DM. Perianal Bowen's disease and associated malignancies: results of a survey. Dis Colon Rectum 1987;30:782–5.

    PubMed  Google Scholar 

  14. Rasmussen OO, Christiansen J. Conservative management of Bowen's disease of the anus. Int J Colorectal Dis 1989;4:164–6.

    PubMed  Google Scholar 

  15. Campbell C, Quinn AG, Ro YS, Angus B, Rees JL. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J Invest Dermatol 1993;100:746–8.

    PubMed  Google Scholar 

  16. McGregor JM, Yu CC, Dublin EA, Levison DA, MacDonald DM. Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer. Br J Dermatol 1992;127:463–9.

    PubMed  Google Scholar 

  17. Ro YS, Cooper PN, Lee JA,et al. p53 protein expression in benign and malignant skin tumours. Br J Dermatol 1993;128:237–41.

    PubMed  Google Scholar 

  18. Baum HP, Meurer I, Unteregger G. Expression of proliferation-associated proteins (proliferating cell nuclear antigen and Ki-67 antigen) in Bowen's disease. Br J Dermatol 1994;131:231–6.

    PubMed  Google Scholar 

  19. Szekeres G, De Giacomoni P. Ki-67 and p53 expression in cutaneous Bowen's disease: an immunohistochemical study of fixed-embedded tissue sections. Acta Derm Venereol (Stockh) 1994;74:95–7.

    Google Scholar 

  20. Bruner J, Connelly J, Saya H. p53 protein immunostaining in routinely processed paraffin-embedded tissues. Mod Pathol 1993;6:189–94.

    PubMed  Google Scholar 

  21. Gerdes J, Becker MH, Key G, Cattoretti G. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 1992;168:85–6.

    PubMed  Google Scholar 

  22. Cattoretti G, Becker MH, Key G,et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357–63.

    PubMed  Google Scholar 

  23. Strauss RJ, Fazio VW. Bowen's disease of the anal and perianal area: a report and analysis of twelve cases. Am J Surg 1979;137:231–4.

    PubMed  Google Scholar 

  24. Arbesman H, Ransohoff DF. Is Bowen's disease a predictor for the development of internal malignancy? A methodological critique of the literature. JAMA 1987;257:516–8.

    PubMed  Google Scholar 

  25. Reymann F, Ravnborg L, Schou G, Engholm G, Osterlind A, Thestrup-Pedersen K. Bowen's disease and internal malignant diseases: a study of 581 patients. Arch Dermatol 1988;124:677–9.

    PubMed  Google Scholar 

  26. Lycka BA. Bowen's disease and internal malignancy: a meta-analysis. Int J Dermatol 1989;28:531–3.

    PubMed  Google Scholar 

  27. Chute CG, Chuang TY, Bergstralh EJ, Su WP. The subsequent risk of internal cancer with Bowen's disease: a population-based study. JAMA 1991;266:816–9.

    PubMed  Google Scholar 

  28. Levine A, Momand J, Finlay C. The p53 tumour suppressor gene. Nature 1991;351:453–6.

    PubMed  Google Scholar 

  29. Hollstein M, Sidransky D, Volgelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49–53.

    PubMed  Google Scholar 

  30. Reich NC, Levine AJ. Growth regulation of a cellular tumor antigen, p53, in nontransformed cells. Nature 1984;308:199–201.

    PubMed  Google Scholar 

  31. Finlay C, Hinds P, Levin A. The p53 procto-oncogen can act as suppressor of transformation. Cell 1989;57:1083–93.

    PubMed  Google Scholar 

  32. Gerdes J, Lemke H, Baisch H, Wacker HH, Shwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710–5.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Colorectal Surgery, Desk A111, The Cleveland Clinic Foundation, 9500 Euclid Avenue, 44195, Cleveland, Ohio

    Pierenrico Marchesa M.D.,  Victor W. Fazio M.D., Soledad Oliart M.D., John R. Goldblum M.D. & Ian C. Lavery M.D.

  2. Department of Pathology, The Cleveland Clinic Foundation, Cleveland, Ohio

    Pierenrico Marchesa M.D.,  Victor W. Fazio M.D., Soledad Oliart M.D., John R. Goldblum M.D. & Ian C. Lavery M.D.

Authors
  1. Pierenrico Marchesa M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Victor W. Fazio M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Soledad Oliart M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John R. Goldblum M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ian C. Lavery M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by the John Wilson Memorial Fund, Cleveland Clinic, Cleveland, Ohio.

Read at the meeting of The American Society of Colon and Rectal Surgeons, Seattle, Washington, June 9 to 14, 1996.

About this article

Cite this article

Marchesa, P., Fazio, V.W., Oliart, S. et al. Perianal Bowen's disease. Dis Colon Rectum 40, 1286–1293 (1997). https://doi.org/10.1007/BF02050810

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02050810

Key words

Search

Navigation